Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Global Outlook and Forecast 2023-2030

Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Global Outlook and Forecast 2023-2030 help@statsmarketresearch.com

(+1)-646-781-7170 (Int'l) (+91)-916-916-4321 (Asia)

Report Overview: 

The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth.

Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.



We surveyed the Chemotherapy-Induced Nausea and Vomiting (CINV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

©All Rights Reserved, Stats Market Research

Market Value: 

The global Chemotherapy-Induced Nausea and Vomiting (CINV) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

CAGR of xx% (2022 – 2029) ©All Rights Reserved, Stats Market Research

By Types: •

CINV

•

PONV

By Applications:

Hospitals Ambulatory Surgical Centers Diagnostic Centers

©All Rights Reserved, Stats Market Research

Key players include: •

Merck

•

Eisai

•

ProStrakan

•

Helsinn Holding

•

Mundipharma

•

Qilu Pharma

•

Teva

Get in touch

(+1)-646-781-7170 (Int'l) help@statsmarketresearch.com

(+91)-916-916-4321 (Asia) www.statsmarketresearch.com

Full Report Url: https://www.statsmarketresearch.com/globalchemotherapyinduced-nausea-vomiting-forecast2023-2030-45-7874054 ©All Rights Reserved, Stats Market Research